SILO PHARMA, INC. (SILO) Return on equity 2020–2025
SILO PHARMA, INC. (SILO) return on equity by fiscal year — reported net income divided by year-end shareholders’ equity.
-67.0%FY2025 · since FY2020: -237.2% → -67.0%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -67.0% | +20.2 pp |
| FY2024 | -87.3% | -27.3 pp |
| FY2023 | -59.9% | -22.1 pp |
| FY2022 | -37.8% | — |
| FY2020 | -237.2% | — |
ROE = reported net income ÷ reported year-end shareholders’ equity for the same fiscal year. Heavy buybacks shrink equity and can push ROE very high (or negative-equity years drop out).
Source: SEC XBRL filings · For reference only · Not investment advice